AcelRx Pharmaceuticals Inc (NASDAQ:ACRX)
| 0.571 Delayed Data As of 3:56pm ET |  -0.0025 / -0.44%Today’s Change | 0.54 Today|||52-Week Range 4.86 | -74.73% Year-to-Date |
Latest ACRX News | Press Releases
No recent news for AcelRx Pharmaceuticals Inc.
Today’s Trading
| Previous close | 0.57 |
| Today’s open | 0.57 |
| Day’s range | 0.55 - 0.58 |
| Volume | 6,992 |
| Average volume (3 months) | 262,850 |
| Market cap | $9.8M |
Data as of 3:56pm ET, 10/04/2023
Growth & Valuation
| Earnings growth (last year) | -- |
| Earnings growth (this year) | -139.51% |
| Earnings growth (next 5 years) | +46.60% |
| Revenue growth (last year) | -37.15% |
| P/E ratio | NM |
| Price/Sales | 9.45 |
| Price/Book | 0.23 |
Competitors
| ---- | ||
| APMAptorum Group Ltd | 0.00 | 0.00% |
| TNXPTonix Pharmaceutical... | +0.04 | +6.63% |
| ATHEAlterity Therapeutic... | -- | -- |
Data as of 3:57pm ET, 10/04/2023
Financials
| Next reporting date | November 9, 2023 |
| EPS forecast (this quarter) | -$0.50 |
| Annual revenue (last year) | $1.8M |
| Annual profit (last year) | $42.5M |
| Net profit margin | 2,400.62% |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters San Mateo, California |
Forecasts
